RLAY vs SANA โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
RLAY Captures Institutional Edge (2โ1 Pillars ยท 5โ2 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Relay Therapeutics, Inc. Common Stock (RLAY) driven by superior Momentum & Technical, Options & Structure while SANA counters with relative strength in Growth & Margin. Fundamentally, RLAY trades at N/M Forward P/E with -3094.6% operating margin (-48.3% YoY revenue) versus SANA at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, RLAY sits in CONSOLIDATION (6th %ile IV; Dealer Gamma Walls on Pro) against SANA sits in BREAKDOWN (4th %ile IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | RLAY | SANA | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $4.0B | $605.3M | Larger Scale | RLAY |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | -48.3% | +0.0% | Higher Growth | SANA |
| Operating Margin (TTM) Profitability | -3094.6% | 0.0% | Higher Margin | SANA |
| Net Profit Margin Profitability | 0.0% | 0.0% | Higher Margin | Tie |
| Return on Equity (ROE) Capital Efficiency | -41.2% | -79.5% | Higher ROE | RLAY |
| 52-Week Range Position Momentum | 74% ($6โ$21) | 1% ($2โ$5) | Stronger Trend | RLAY |
| Beta / 30D Volatility Risk Regime | 1.70ฮฒ ยท 78% Vol | 1.82ฮฒ ยท 78% Vol | Lower Realized Risk | RLAY |
| Unified Institutional Score Composite Signal | 50.0 / 100 (HOLD) | 44.3 / 100 (HOLD) | Higher Composite | RLAY |